Literature DB >> 10612325

Adefovir for the treatment of HIV infection: if not now, when?

J W Mellors.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10612325     DOI： 10.1001/jama.282.24.2355

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  2 in total

1.  Human immunodeficiency virus (HIV) Type 1 reverse transcriptase resistance mutations in hepatitis B virus (HBV)-HIV-coinfected patients treated for HBV chronic infection once daily with 10 milligrams of adefovir dipivoxil combined with lamivudine.

Authors:  Constance Delaugerre; Anne-Geneviève Marcelin; Vincent Thibault; Gilles Peytavin; Tony Bombled; Marie-Valérie Bochet; Christine Katlama; Yves Benhamou; Vincent Calvez
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

2.  Molecular Mechanisms for Species Differences in Organic Anion Transporter 1, OAT1: Implications for Renal Drug Toxicity.

Authors:  Ling Zou; Adrian Stecula; Anshul Gupta; Bhagwat Prasad; Huan-Chieh Chien; Sook Wah Yee; Li Wang; Jashvant D Unadkat; Simone H Stahl; Katherine S Fenner; Kathleen M Giacomini
Journal:  Mol Pharmacol       Date:  2018-05-02       Impact factor: 4.436
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.